2-Methyl-2-propanyl 1-(aminomethyl)-3,4-dihydro-2(1H)-isoquinolinecarboxylate(CAS: 1207175-15-2)

This compound falls under various regulatory guidelines including GHS classification, REACH regulations, and FDA and EPA requirements. GHS classifies it based on its potential health and environmental hazards. REACH regulations require manufacturers and importers to register substances if they have not already been registered. FDA may regulate its use in pharmaceuticals, while EPA oversees its use in industrial settings. Compliance with these guidelines ensures safe handling and use.

Several alternatives can be used in its synthesis, such as 2-methyl-2-propanol and aminomethyl-substituted isoquinoline derivatives. These alternatives can provide similar functionalities with potentially lower toxicity or better reactivity. It is essential to evaluate each option based on specific application requirements and regulatory compliance.

The compound shows growing interest in pharmaceutical research due to its potential as a drug candidate. Market trends indicate increasing demand for its use in developing new therapeutic agents. Research is focusing on its biological activity, pharmacokinetics, and potential side effects. Additionally, there is a trend towards exploring its use in organic synthesis as a versatile starting material.

Waste containing this compound should be collected in appropriate containers and stored in a secure, well-ventilated area. It is advisable to incinerate or use professional waste disposal services to ensure it is handled safely. Environmental protection measures include proper labeling of waste containers,遵守当地法规, 并采取适当的安全预防措施以防止泄漏或污染。